Market Trends in the Use of Nucleic Acid Technologies to Treat Neurological Disorders

Time: 8:35 am
day: Day One


• Focusing on how novel technologies in the nucleic acid space (gene therapies, ASOs, gene editing) will shape the market in neurological indications
• Exploring the use of these technologies in large indications (e.g, Alzheimers) compare to rare diseases
• How this supposes a paradigm shift at so many levels (for industry, CMOs, practitioners, payers and regulatory agencies)